Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview

Area of Science:

• Hepatology and Oncology
• Epidemiology
• Public Health Policy

Background:

• Hepatocellular carcinoma (HCC) is a significant global health concern with varying epidemiological data worldwide.
• Egypt faces a substantial burden of HCC, ranking fourth in incidence within the country.
• Understanding these variations is crucial for developing effective, localized strategies.

Purpose of the Study:

• To conduct a comparative analysis of Hepatocellular Carcinoma (HCC) status in Egypt versus global trends.
• To examine key aspects including risk factors, screening and surveillance, diagnosis, treatment, prevention, and research strategies.
• To identify areas for improvement and inform future public health initiatives in Egypt.

Main Methods:

• Review and synthesis of existing literature on HCC epidemiology, risk factors, and management.
• Comparative analysis of HCC data and strategies between Egypt and worldwide.
• Assessment of current screening, surveillance, diagnosis, and treatment protocols in Egypt.

Main Results:

• Egypt exhibits specific environmental and host-related risk factors for HCC.
• Significant improvements in HCC screening and surveillance have been observed in Egypt, notably the 2018 national campaign.
• Challenges remain in HCC prevention policy implementation, treatment cost limitations, and a scarcity of Egyptian data on survival and relapse.
• Both basic and clinical HCC research in Egypt are limited compared to global standards.

Conclusions:

• Tailoring efforts to address country-specific factors, like those in Egypt, is essential for managing HCC burden.
• Establishing a dedicated research strategy for HCC in Egypt can optimize resource allocation.
• Such a strategy aims to reduce HCC incidence and mortality while enhancing patient quality of life.